• 1. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 2. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 3. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 4. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 5. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991

Recent Advances in the Synthesis and Applications of (5-Methyl-2-(trifluoromethyl)phenyl)methanol (CAS: 886502-81-4)

The compound (5-Methyl-2-(trifluoromethyl)phenyl)methanol (CAS: 886502-81-4) has garnered significant attention in recent years due to its versatile applications in pharmaceutical and chemical synthesis. This aromatic alcohol, characterized by a trifluoromethyl group and a methyl substituent on the phenyl ring, serves as a key intermediate in the development of bioactive molecules. Recent studies have focused on optimizing its synthesis, exploring its reactivity, and evaluating its potential in drug discovery and material science.

A 2023 study published in the Journal of Medicinal Chemistry highlighted the role of (5-Methyl-2-(trifluoromethyl)phenyl)methanol in the synthesis of novel kinase inhibitors. The researchers demonstrated that this compound could be efficiently converted into a series of derivatives with potent inhibitory activity against specific cancer-related kinases. The study emphasized the importance of the trifluoromethyl group in enhancing the metabolic stability and binding affinity of the resulting inhibitors. These findings open new avenues for the design of targeted therapies for oncology.

In addition to its pharmaceutical applications, (5-Methyl-2-(trifluoromethyl)phenyl)methanol has been investigated for its utility in agrochemicals. A recent patent (WO2023056123) disclosed its use as a building block for fungicides with improved efficacy and environmental safety. The patent highlighted the compound's ability to introduce both lipophilic and electron-withdrawing properties into the final agrochemical products, thereby enhancing their performance in field trials.

From a synthetic chemistry perspective, advances in catalytic methods have streamlined the production of (5-Methyl-2-(trifluoromethyl)phenyl)methanol. A 2024 report in Organic Letters described a palladium-catalyzed reductive carboxylation protocol that enables the efficient conversion of readily available precursors into this valuable intermediate. The method offers high yields and excellent functional group tolerance, making it suitable for large-scale applications. This development is particularly significant for industrial-scale production, where cost-effectiveness and scalability are critical.

Looking ahead, the unique structural features of (5-Methyl-2-(trifluoromethyl)phenyl)methanol continue to inspire innovation across multiple disciplines. Its combination of aromatic stability, fluorine-based electronic effects, and synthetic versatility positions it as a cornerstone in modern chemical research. Future studies are expected to explore its potential in emerging areas such as fluorinated polymers and advanced materials, further expanding its impact beyond traditional applications.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)